Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Patient Monitoring Devices Market, By Product

7.1. Patient Monitoring Devices Market, by Product Type, 2023-2032

7.1.1. Cardiac Monitoring Devices

7.1.1.1. Market Revenue and Forecast (2021-2032)

7.1.2. Blood Glucose Monitoring Systems

7.1.2.1. Market Revenue and Forecast (2021-2032)

7.1.3. Multi-parameter Monitoring Devices

7.1.3.1. Market Revenue and Forecast (2021-2032)

7.1.4. Temperature Monitoring Devices

7.1.4.1. Market Revenue and Forecast (2021-2032)

7.1.5. Respiratory Monitoring Devices

7.1.5.1. Market Revenue and Forecast (2021-2032)

7.1.6. Hemodynamic/Pressure Monitoring Devices

7.1.6.1. Market Revenue and Forecast (2021-2032)

7.1.7. Fetal & Neonatal Monitoring Devices

7.1.7.1. Market Revenue and Forecast (2021-2032)

7.1.8. Neuromonitoring Devices

7.1.8.1. Market Revenue and Forecast (2021-2032)

7.1.9. Weight Monitoring Devices

7.1.9.1. Market Revenue and Forecast (2021-2032)

7.1.10. Others

7.1.10.1. Market Revenue and Forecast (2021-2032)

Chapter 8. Global Patient Monitoring Devices Market, By End-use

8.1. Patient Monitoring Devices Market, by End-use, 2023-2032

8.1.1. Hospitals

8.1.1.1. Market Revenue and Forecast (2021-2032)

8.1.2. Home Care Settings

8.1.2.1. Market Revenue and Forecast (2021-2032)

8.1.3. Ambulatory Surgery Centers

8.1.3.1. Market Revenue and Forecast (2021-2032)

8.1.4. Others

8.1.4.1. Market Revenue and Forecast (2021-2032)

Chapter 9. Global Patient Monitoring Devices Market, Regional Estimates and Trend Forecast

9.1. North America

9.1.1. Market Revenue and Forecast, by Product (2021-2032)

9.1.2. Market Revenue and Forecast, by End-use (2021-2032)

9.1.3. U.S.

9.1.3.1. Market Revenue and Forecast, by Product (2021-2032)

9.1.3.2. Market Revenue and Forecast, by End-use (2021-2032)

9.1.4. Rest of North America

9.1.4.1. Market Revenue and Forecast, by Product (2021-2032)

9.1.4.2. Market Revenue and Forecast, by End-use (2021-2032)

9.2. Europe

9.2.1. Market Revenue and Forecast, by Product (2021-2032)

9.2.2. Market Revenue and Forecast, by End-use (2021-2032)

9.2.3. UK

9.2.3.1. Market Revenue and Forecast, by Product (2021-2032)

9.2.3.2. Market Revenue and Forecast, by End-use (2021-2032)

9.2.4. Germany

9.2.4.1. Market Revenue and Forecast, by Product (2021-2032)

9.2.4.2. Market Revenue and Forecast, by End-use (2021-2032)

9.2.5. France

9.2.5.1. Market Revenue and Forecast, by Product (2021-2032)

9.2.5.2. Market Revenue and Forecast, by End-use (2021-2032)

9.2.6. Rest of Europe

9.2.6.1. Market Revenue and Forecast, by Product (2021-2032)

9.2.6.2. Market Revenue and Forecast, by End-use (2021-2032)

9.3. APAC

9.3.1. Market Revenue and Forecast, by Product (2021-2032)

9.3.2. Market Revenue and Forecast, by End-use (2021-2032)

9.3.3. India

9.3.3.1. Market Revenue and Forecast, by Product (2021-2032)

9.3.3.2. Market Revenue and Forecast, by End-use (2021-2032)

9.3.4. China

9.3.4.1. Market Revenue and Forecast, by Product (2021-2032)

9.3.4.2. Market Revenue and Forecast, by End-use (2021-2032)

9.3.5. Japan

9.3.5.1. Market Revenue and Forecast, by Product (2021-2032)

9.3.5.2. Market Revenue and Forecast, by End-use (2021-2032)

9.3.6. Rest of APAC

9.3.6.1. Market Revenue and Forecast, by Product (2021-2032)

9.3.6.2. Market Revenue and Forecast, by End-use (2021-2032)

9.4. MEA

9.4.1. Market Revenue and Forecast, by Product (2021-2032)

9.4.2. Market Revenue and Forecast, by End-use (2021-2032)

9.4.3. GCC

9.4.3.1. Market Revenue and Forecast, by Product (2021-2032)

9.4.3.2. Market Revenue and Forecast, by End-use (2021-2032)

9.4.4. North Africa

9.4.4.1. Market Revenue and Forecast, by Product (2021-2032)

9.4.4.2. Market Revenue and Forecast, by End-use (2021-2032)

9.4.5. South Africa

9.4.5.1. Market Revenue and Forecast, by Product (2021-2032)

9.4.5.2. Market Revenue and Forecast, by End-use (2021-2032)

9.4.6. Rest of MEA

9.4.6.1. Market Revenue and Forecast, by Product (2021-2032)

9.4.6.2. Market Revenue and Forecast, by End-use (2021-2032)

9.5. Latin America

9.5.1. Market Revenue and Forecast, by Product (2021-2032)

9.5.2. Market Revenue and Forecast, by End-use (2021-2032)

9.5.3. Brazil

9.5.3.1. Market Revenue and Forecast, by Product (2021-2032)

9.5.3.2. Market Revenue and Forecast, by End-use (2021-2032)

9.5.4. Rest of LATAM

9.5.4.1. Market Revenue and Forecast, by Product (2021-2032)

9.5.4.2. Market Revenue and Forecast, by End-use (2021-2032)

Chapter 10. Company Profiles

10.1. Abbott Laboratories

10.1.1. Company Overview

10.1.2. Product Offerings

10.1.3. Financial Performance

10.1.4. Recent Initiatives

10.2. Hill-Rom Holdings, Inc.

10.2.1. Company Overview

10.2.2. Product Offerings

10.2.3. Financial Performance

10.2.4. Recent Initiatives

10.3. Drägerwerk AG & Co. KGaA

10.3.1. Company Overview

10.3.2. Product Offerings

10.3.3. Financial Performance

10.3.4. Recent Initiatives

10.4. Edwards Lifesciences Corporation

10.4.1. Company Overview

10.4.2. Product Offerings

10.4.3. Financial Performance

10.4.4. Recent Initiatives

10.5. OMRON Corporation

10.5.1. Company Overview

10.5.2. Product Offerings

10.5.3. Financial Performance

10.5.4. Recent Initiatives

10.6. Masimo Corporation

10.6.1. Company Overview

10.6.2. Product Offerings

10.6.3. Financial Performance

10.6.4. Recent Initiatives

10.7. Compumedics Limited

10.7.1. Company Overview

10.7.2. Product Offerings

10.7.3. Financial Performance

10.7.4. Recent Initiatives

10.8. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

10.8.1. Company Overview

10.8.2. Product Offerings

10.8.3. Financial Performance

10.8.4. Recent Initiatives

10.9. Nihon Kohden Corporation

10.9.1. Company Overview

10.9.2. Product Offerings

10.9.3. Financial Performance

10.9.4. Recent Initiatives

10.10. Natus Medical

10.10.1. Company Overview

10.10.2. Product Offerings

10.10.3. Financial Performance

10.10.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research

11.2. Secondary Research

11.3. Assumptions

Chapter 12. Appendix

12.1. About Us

12.2. Glossary of Terms